Non-sulphated cholecystokinin in human medullary thyroid carcinomas

in Journal of Endocrinology
Authors:
J. F. Rehfeld
Search for other papers by J. F. Rehfeld in
Current site
Google Scholar
PubMed
Close
,
A. H. Johnsen
Search for other papers by A. H. Johnsen in
Current site
Google Scholar
PubMed
Close
,
L. Ødum
Search for other papers by L. Ødum in
Current site
Google Scholar
PubMed
Close
,
L. Bardram
Search for other papers by L. Bardram in
Current site
Google Scholar
PubMed
Close
,
S. Schifter
Search for other papers by S. Schifter in
Current site
Google Scholar
PubMed
Close
, and
L. Scopsi
Search for other papers by L. Scopsi in
Current site
Google Scholar
PubMed
Close
Restricted access
Rent on DeepDyve

Sign up for journal news

ABSTRACT

The expression of gastrin/cholecystokinin (CCK) peptides and their precursors was examined in 16 medullary carcinomas of the human thyroid. Measurements with libraries of sequence-specific radioimmunoassays before and after enzymatic cleavage of extracts and chromatographic fractions showed that the carcinomas contained 1·7 pmol carboxyamidated CCK/g tissue (median; range 0·6–21·8 pmol/g), 0·9 pmol glycine-extended precursor/g (median; range < 0·2–2·3 pmol/g) and 2·3 pmol further COOH-terminal-extended proCCK/g (median; range 0·9–6·2 pmol/g). Neither carboxyamidated gastrins nor any progastrins could be measured. Gel and reverse-phase chromatography revealed only small molecular forms, i.e. > 90% of the amidated immunoreactivity eluted like non-sulphated CCK-8 or CCK-7. The results show that human medullary thyroid carcinomas synthesize CCK peptides. The predominance of non-sulphated CCK is unusual. Taken together with earlier observations from dogs and pigs, our results raise the possibility that small non-sulphated CCK peptides modulate thyroid C-cell secretion in an autocrine manner.

Journal of Endocrinology (1990) 124, 501–506

 

  • Collapse
  • Expand